Artificial Intelligence Driven Innovation: Advancing Mesenchymal Stem Cell Therapies and Intelligent Biomaterials for Regenerative Medicine

Mengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman · 2025

Read Artificial Intelligence Driven Innovation: Advancing Mesenchymal Stem Cell Therapies and Intelligent Biomaterials for Regenerative Medicine by Mengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12729526.txt.

Description

Artificial intelligence (AI) is revolutionizing regenerative medicine, particularly in advancing mesenchymal stem cell (MSC) therapies and smart biomaterials. This review highlights AI’s role in two core areas: First, at the biological level, AI can be used to predict MSC differentiation, immunomodulatory function, and therapeutic potential by analyzing multi-omics and imaging data, deciphering heterogeneity and improving precision.

Catalog record

CREATORMengyu Huang, Waruna Lakmal Dissanayaka, Cynthia K Y Yiu, Huang Chun-Yuh, Stuart Goodman
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE69 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12729526

Browse the full library · About the Tower of Babel